In 2025, AI and machine learning are set to significantly amplify the impact of CRISPR genome editing across multiple fields, including medicine, agriculture, climate change, and the foundational research driving these areas. While the AI field is filled with grand promises, it’s important to recognize that real, tangible advancements are already occurring in genomics and life sciences. Unlike many technological breakthroughs that take years to show results, the fusion of AI and CRISPR is already transforming the way we approach genetic research.
In genomics, where vast datasets are the norm, researchers often face a challenge: even supercomputers can take weeks or months to analyze subsets of data. As a result, we’re forced to limit the scope of our inquiries, focusing only on the most manageable datasets. AI and machine learning are now breaking these barriers, enabling us to quickly analyze complex genomic data. In my own lab, for example, we used AI to discover small gene-editing proteins that had been hidden in public genome databases—simply because we lacked the computational tools to uncover them before.
At the Innovative Genomics Institute, which I founded at UC Berkeley, we recently collaborated with experts from the Department of Electrical Engineering and Computer Sciences (EECS) and the Center for Computational Biology. Together, we developed a large language model—similar to the ones used by popular chatbots—that can predict RNA molecules with better heat tolerance than natural sequences. This breakthrough opens up exciting possibilities for genomic research, suggesting that many more hidden discoveries are waiting to be made in the expansive genome and structural databases accumulated over the last few decades.
These advancements aren’t just theoretical—they have real-world implications. For example, more efficient gene-editing proteins could enhance the delivery of therapies into cells, while heat-stable RNA molecules could optimize biomanufacturing processes, making medicines and other essential products more efficient and scalable.
In the realm of healthcare and drug development, AI is already playing a pivotal role. The recent approval of the first CRISPR-based therapy for sickle cell disease marks a major milestone, and with approximately 7,000 other genetic diseases still awaiting treatment, AI has the potential to accelerate the development of therapies. By predicting the best editing targets, maximizing CRISPR’s precision, and minimizing off-target effects, AI can significantly speed up the process of creating effective treatments.
AI and CRISPR also hold great promise in agriculture. With AI-driven CRISPR advancements, scientists are working on creating more resilient, productive, and nutritious crops. These innovations will play a key role in ensuring global food security and reducing the time it takes to bring improved crops to market. In the fight against climate change, AI and CRISPR could lead to breakthroughs in natural carbon capture and environmental sustainability, helping mitigate some of the most pressing challenges facing our planet.
Though we’re still in the early stages of this technological revolution, the combined potential of AI and CRISPR—two of the most profound innovations of our time—is already unfolding in exciting and impactful ways. The future is bright, and we are only beginning to scratch the surface of what’s possible.
By Impact Lab
